Correcting non cephalic presentation with moxibustion: Study protocol for a multi-centre randomised controlled trial in general practice

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10634508

Enrollment

492

Registered

2008-04-30

Start date

2008-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non cephalic presentation of fetus Pregnancy and Childbirth Maternal care for known or suspected malpresentation of fetus

Interventions

All the study subjects will be given various postural recommendations. The participants will be randomly allocated to the following three arms: Arm A: True moxibustion (TM): The first intervention

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women 2. Aged at least 18 years 3. Foetus is in a non cephalic position (diagnosed by physical examination and by echography) 4. Gestational age of 33-35 weeks (estimated by echography) 5. Normal foetal biometry 6. Those who have signed their informed consent 7. Have not previously received moxibustion treatment to correct the position of their unborn baby

Exclusion criteria

Exclusion criteria: 1. Twin pregnancy 2. Pelvic defect 3. Previous uterine surgery 4. Foetal malformation or chromosome disorder 5. Uterine malformation 6. Risk of premature birth (preterm uterine contractions and/or initial dilation or shortening of the cervix with a Bishop's score of 4) 7. Uterine fibromas >4 cm 8. Treatment with tocolytic drugs 9. Heart or kidney disease affecting the mother 10. Other pregnancy-related complications 11. Inability to complete the questionnaire or respond to the assessor's questions

Design outcomes

Primary

Measure	Time frame
Rate of cephalic presentation at term.	—

Secondary

Measure	Time frame
1. Rate of cephalic presentation at week 38 of gestation (CP38), determined by echography 2. Number of days of treatment received until version occurs 3. Rate of caesarean sections 4. Security variables: 4.1. Increased rates of foetal cardiac rhythm change, followed-up until birth 4.2. Risk of premature birth 4.3. Changes in Apgar scores at 1 minute and at 5 minutes 1. Rate of cephalic presentation at week 38 of gestation (CP38), determined by echography 2. Number of days of treatment received until version occurs 3. Rate of caesarean sections 4. Security variables: 4.1. Increased rates of foetal cardiac rhythm change 4.2. Risk of premature birth 4.3. Changes in Apgar scores at 1 minute and at 5 minutes	—

Measure

Time frame

1. Rate of cephalic presentation at week 38 of gestation (CP38), determined by echography 2. Number of days of treatment received until version occurs 3. Rate of caesarean sections 4. Security variables: 4.1. Increased rates of foetal cardiac rhythm change, followed-up until birth 4.2. Risk of premature birth 4.3. Changes in Apgar scores at 1 minute and at 5 minutes 1. Rate of cephalic presentation at week 38 of gestation (CP38), determined by echography 2. Number of days of treatment received until version occurs 3. Rate of caesarean sections 4. Security variables: 4.1. Increased rates of foetal cardiac rhythm change 4.2. Risk of premature birth 4.3. Changes in Apgar scores at 1 minute and at 5 minutes

—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026